A Mechanistically Novel, First Oral Therapy for Multiple Sclerosis: The Development of Fingolimod (FTY720, Gilenya) - Jerold Chun - Discovery Medicine
Monoclonal Antibody Therapy in Multiple Sclerosis - Practical Neurology
The use of immune modulating drugs for the treatment of multiple sclerosis | Neurosciences Journal
Proposed Mechanism of Action (MOA) | TYSABRI® (natalizumab) HCP
Potential mechanisms of action related to the efficacy and safety of cladribine - Multiple Sclerosis and Related Disorders
Natalizumab | Nature Reviews Drug Discovery
Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project - The Lancet Oncology
Natalizumab and glatiramer acetate mechanism of action. A. Natalizumab... | Download Scientific Diagram
Natalizumab blocks lymphocyte homing in MS. (A) 4 integrin binds to... | Download Scientific Diagram
Natalizumab - Wikipedia
Eosinophilia during natalizumab treatment: Incidence, risk factors and temporal patterns - ScienceDirect
Currently Approved Disease-Modifying Drugs: Monoclonal Antibody Natalizumab - ScienceDirect
Natalizumab (Tysabri). - Abstract - Europe PMC
Aaron Boster MD on Twitter: "Click to learn how Tysabri (Natalizumab) works in #MS: https://t.co/TUYQqJTzQo #MultipleSclerosis #Tysabri https://t.co/WC7xvLO3EK" / Twitter
Natalizumab (Tysabri) | American Journal of Neuroradiology
Natalizumab - Wikipedia
Multiple Sclerosis: Mechanisms and Immunotherapy - ScienceDirect
Natalizumab for Multiple Sclerosis | NEJM
Natalizumab treatment of multiple sclerosis: new insights | Immunotherapy
Treating Multiple Sclerosis With Monoclonal Antibodies
Identification and development of new therapeutics for multiple sclerosis: Trends in Pharmacological Sciences
Brain Sciences | Free Full-Text | Clinical Immunological Correlations in Patients with Multiple Sclerosis Treated with Natalizumab
Emerging Therapies for Progressive Multiple Sclerosis - Practical Neurology
Multiple Sclerosis: Mechanisms and Immunotherapy - ScienceDirect
